Medicamen Biotech informs about closure of trading window

31 Mar 2025 Evaluate

In terms of the provisions of the Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relative (‘the Code’), Medicamen Biotech has informed that the ‘Trading Window’ for dealing in the securities of the Company will be closed for all Directors / Designated Persons /Connected Persons under the Code from April 01, 2025 and the same will remain closed till 48 hours after the declaration of Audited Financial Results (Standalone & Consolidated) for the quarter and year ended on March 31, 2025, to the public. Accordingly, all Directors / Designated Persons / Connected Persons under the Code have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. The date of meeting of the Board of Directors of the Company, to approve the Audited Financial Results (Standalone & Consolidated) of the Company for the aforesaid period will be intimated separately in due course of time.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

426.25 -11.65 (-2.66%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...